Ruliang Xu

6.7k total citations · 2 hit papers
75 papers, 5.5k citations indexed

About

Ruliang Xu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ruliang Xu has authored 75 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Epidemiology. Recurrent topics in Ruliang Xu's work include Immune Response and Inflammation (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer-related gene regulation (5 papers). Ruliang Xu is often cited by papers focused on Immune Response and Inflammation (8 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer-related gene regulation (5 papers). Ruliang Xu collaborates with scholars based in United States, China and Switzerland. Ruliang Xu's co-authors include Lennart Philipson, Masayuki Fukata, María T. Abreu, Anli Chen, J. Charles Whitbeck, Roselyn J. Eisenberg, Gary H. Cohen, Patricia G. Spear, Rebecca I. Montgomery and Arunan S. Vamadevan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Ruliang Xu

71 papers receiving 5.4k citations

Hit Papers

HCAR and MCAR: The human and mouse cellular receptors for... 1997 2026 2006 2016 1997 2007 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
    1997 1.0k citations Ruliang Xu et al. profile →
  2. Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
    2007 522 citations Masayuki Fukata, Anli Chen et al. Gastroenterology profile →

Peers

Ruliang Xu
Paul L. Hermonat United States
Andrew J. Dorner United States
Sander van Deventer Netherlands
Stephen T. Smiley United States
Timothy Harris United States
Cindy Luongo United States
Ta‐Chiang Liu United States
Margaret Karow United States
Hitoshi Asakura Japan
Massimo Claudio Fantini Italy
Paul L. Hermonat United States
Ruliang Xu
Citations per year, relative to Ruliang Xu Ruliang Xu (= 1×) peers Paul L. Hermonat

Countries citing papers authored by Ruliang Xu

Since Specialization
Citations

This map shows the geographic impact of Ruliang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruliang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruliang Xu more than expected).

Fields of papers citing papers by Ruliang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruliang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruliang Xu. The network helps show where Ruliang Xu may publish in the future.

Co-authorship network of co-authors of Ruliang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruliang Xu. A scholar is included among the top collaborators of Ruliang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruliang Xu. Ruliang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuguang, Hui Gong, Yixuan Li, et al.. (2025). Chemotherapy-induced macrophage CXCL7 expression drives tumor chemoresistance via the STAT1/PHGDH-serine metabolism axis and SAM paracrine feedback to M2 polarization. Cell Death and Disease. 16(1). 379–379. 2 indexed citations
2.
3.
4.
Xu, Qiao, Hongchuan Xin, Rui Wu, et al.. (2023). 495P Intrinsic STING of CD8+T cells regulates self-metabolic reprogramming and exerts anti-tumor effects. Annals of Oncology. 34. S1656–S1656. 1 indexed citations
5.
6.
Adam, Benjamin, Iyare Izevbaye, Ruliang Xu, et al.. (2019). Abstracts from USCAP 2019: Gastrointestinal Pathology (578-775). Laboratory Investigation. 99(Suppl 1). 1–164. 3 indexed citations
7.
Adam, Benjamin, Iyare Izevbaye, Ruliang Xu, et al.. (2019). Abstracts from USCAP 2019: Gastrointestinal Pathology (578-775). Modern Pathology. 32(Suppl 2). 1–164.
8.
Xu, Ruliang, et al.. (2017). Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World Journal of Hepatology. 9(6). 300–300. 72 indexed citations
9.
Court, Helen, Marc Amoyel, Kyoung Eun Lee, et al.. (2013). Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. Journal of Clinical Investigation. 123(11). 4681–4694. 41 indexed citations
10.
Günal, Armağan, Pei Hui, Selim Kılıç, et al.. (2012). KRAS Mutations are Associated With Specific Morphologic Features in Colon Cancer. Journal of Clinical Gastroenterology. 47(6). 509–514. 14 indexed citations
11.
Ligr, Martin, Ruzeen Patwa, Garrett Daniels, et al.. (2011). Correction: Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer. PLoS ONE. 6(10). 11 indexed citations
12.
Ligr, Martin, Ruzeen Patwa, Garrett Daniels, et al.. (2011). Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer. PLoS ONE. 6(10). e26250–e26250. 39 indexed citations
13.
Wu, Xinyu, Fei Chen, Ayşegül A. Şahin, et al.. (2010). Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer. Breast Cancer Research and Treatment. 128(2). 391–400. 15 indexed citations
14.
Ungaro, Ryan C., Masayuki Fukata, David S. Hsu, et al.. (2009). A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(6). G1167–G1179. 138 indexed citations
15.
Fukata, Masayuki, Anli Chen, Arunan S. Vamadevan, et al.. (2007). Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors. Gastroenterology. 133(6). 1869–1869.e14. 522 indexed citations breakdown →
16.
Xu, Ruliang, et al.. (2007). Hepatocellular Carcinoma Associated with an Atypical Presentation of Wilson's Disease. Seminars in Liver Disease. 27(1). 122–127. 16 indexed citations
17.
Fiel, Maria Isabel, et al.. (2007). Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transplant Infectious Disease. 10(3). 184–189. 10 indexed citations
18.
Fukata, Masayuki, Anli Chen, Arielle Klepper, et al.. (2006). Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) Signaling: Role in Proliferation and Apoptosis in the Intestine. Gastroenterology. 131(3). 862–877. 371 indexed citations
19.
Suriawinata, Arief A. & Ruliang Xu. (2004). An Update on the Molecular Genetics of Hepatocellular Carcinoma. Seminars in Liver Disease. 24(1). 77–88. 92 indexed citations
20.
Xu, Ruliang, Shuji Ogino, Va Lip, Hong Fang, & Bai‐Lin Wu. (2003). Comparison of PCR-RFLP with Allele-Specific PCR in Genetic Testing for Spinal Muscular Atrophy. Genetic Testing. 7(4). 277–281. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul L. Hermonat Breakdown of academic impact, for papers by Andrew J. Dorner Breakdown of academic impact, for papers by Sander van Deventer Breakdown of academic impact, for papers by Stephen T. Smiley Breakdown of academic impact, for papers by Timothy Harris Breakdown of academic impact, for papers by Cindy Luongo Breakdown of academic impact, for papers by Ta‐Chiang Liu Breakdown of academic impact, for papers by Margaret Karow Breakdown of academic impact, for papers by Hitoshi Asakura Breakdown of academic impact, for papers by Massimo Claudio Fantini
Rankless by CCL
2026